Citadel Advisors
PRAH

Citadel Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Citadel Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,600
Closed -$430K – 15362
2021
Q2 		$430K Sell
2,600
-14,600
-85% -$2.44M ﹤0.01% 10396
2021
Q1 		$2.64M Sell
17,200
-900
-5% -$122K ﹤0.01% 5747
2020
Q4 		$2.27M Buy
18,100
+12,600
+229% +$1.41M ﹤0.01% 5099
2020
Q3 		$558K Sell
5,500
-4,400
-44% -$449K ﹤0.01% 7099
2020
Q2 		$963K Sell
9,900
-5,300
-35% -$493K ﹤0.01% 5902
2020
Q1 		$1.26M Buy
15,200
+8,900
+141% +$868K ﹤0.01% 4922
2019
Q4 		$700K Sell
6,300
-3,300
-34% -$339K ﹤0.01% 6243
2019
Q3 		$953K Sell
9,600
-15,500
-62% -$1.54M ﹤0.01% 5680
2019
Q2 		$2.49M Sell
25,100
-9,600
-28% -$916K ﹤0.01% 4148
2019
Q1 		$3.83M Buy
34,700
+22,200
+178% +$2.32M ﹤0.01% 3376
2018
Q4 		$1.15M Sell
12,500
-4,600
-27% -$465K ﹤0.01% 5094
2018
Q3 		$1.88M Buy
17,100
+6,700
+64% +$698K ﹤0.01% 4523
2018
Q2 		$971K Sell
10,400
-400
-4% -$34.4K ﹤0.01% 5269
2018
Q1 		$896K Sell
10,800
-2,500
-19% -$222K ﹤0.01% 4988
2017
Q4 		$1.21M Buy
13,300
+4,000
+43% +$333K ﹤0.01% 4382
2017
Q3 		$708K Buy
9,300
+1,600
+21% +$121K ﹤0.01% 4826
2017
Q2 		$578K Buy
7,700
+1,300
+20% +$90.1K ﹤0.01% 4918
2017
Q1 		$417K Buy
+6,400
New +$377K ﹤0.01% 5334

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Citadel Advisors's PRAH Position: Q3 2021 in Review

Citadel Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 572,994 shares — an estimated $94.7M sold.

Citadel Advisors first reported a position in PRAH in Q1 2015 and held it in 23 quarters. The position peaked at $118M in Q3 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Citadel Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Citadel Advisors sold 572,994 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $94.7M.
  • Citadel Advisors first reported a position in PRA Health Sciences, Inc. in Q1 2015 and held it in 23 quarters.
  • Citadel Advisors's PRA Health Sciences, Inc. position peaked at $118M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.